RP Bio Inc. (KOSDAQ:314140)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,760.00
+150.00 (2.67%)
At close: May 29, 2026
Market Cap46.97B -1.5%
Revenue (ttm)137.35B +9.5%
Net Income5.60B +328.6%
EPS647.53 +328.2%
Shares Out 8.67M
PE Ratio8.37
Forward PEn/a
Dividend50.00 (0.89%)
Ex-Dividend DateDec 29, 2025
Volume10,027
Open5,750.00
Previous Close5,610.00
Day's Range5,510.00 - 5,820.00
52-Week Range5,400.00 - 9,130.00
Beta0.46
Analystsn/a
Price Targetn/a
Earnings Daten/a

About RP Bio

RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, antihistamine, and chewable soft capsules; hard capsules; and jelly and powder sticks; Urusa, flagship soft capsule; omega-3 and lutein products, and granule, effervescent granule, and stick type capsule powders. The company also provides cold and liver medicines; vitamins; blood circulation improvers; and pain relievers. The company was founded in 1983 and is headquartered in... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 314140
Full Company Profile

Financial Performance

Financial Statements